Empresa GTx, Inc. Nasdaq
Acciones
US40052B1089
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Oncology Therapies
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -47,32 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
James Breitmeyer
FOU | Founder | 70 | 01/01/97 |
Richard Vincent
DFI | Director of Finance/CFO | 61 | 01/04/17 |
Salim Yazji
CTO | Chief Tech/Sci/R&D Officer | 55 | 17/05/21 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 51 | 28/08/19 |
Pablo Urbaneja
PRN | Corporate Officer/Principal | - | 01/07/21 |
Anita Wiseth
HRO | Human Resources Officer | - | 01/03/21 |
Chase Leavitt
LAW | General Counsel | 42 | 12/04/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Hale
FOU | Founder | 75 | 01/01/97 |
Dan Kisner
BRD | Director/Board Member | 77 | 07/06/19 |
Rosemary Mazanet
BRD | Director/Board Member | 67 | 27/01/21 |
James Breitmeyer
FOU | Founder | 70 | 01/01/97 |
William LaRue
BRD | Director/Board Member | 73 | 01/12/17 |
Michael Carter
BRD | Director/Board Member | 86 | 07/06/19 |
Charles Theuer
BRD | Director/Board Member | 60 | 01/05/18 |
Jill DeSimone
BRD | Director/Board Member | 68 | 03/01/23 |
Robert Wills
BRD | Director/Board Member | 70 | 07/06/19 |
Xin Nakanishi
BRD | Director/Board Member | 62 | 01/11/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 2 959 645 | 2 686 463 ( 90,77 %) | 0 | 90,77 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+17,96 % | 44,96 mil M | |
+1,17 % | 42,65 mil M | |
+48,77 % | 41,85 mil M | |
-4,27 % | 29,04 mil M | |
+11,42 % | 26,08 mil M | |
-21,39 % | 19,03 mil M | |
+4,86 % | 12,75 mil M | |
+27,29 % | 12,06 mil M | |
-3,50 % | 11,75 mil M |